Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Exelixis signs CRADA for cabozantinib with National Cancer Institute

Nov. 29, 2011

University of Cambridge and Elan launch center for research focused on neurodegenerative disorders

Nov. 29, 2011

biOasis enters agreement with Shire Human Genetic Therapies

Nov. 28, 2011

Daiichi Sankyo and Provepharm enter license agreement for methylthioninium chloride in Japan

Nov. 25, 2011

Aeterna Zentaris licenses anticancer agent to Hikma

Nov. 24, 2011

UCB decides on option agreement to license SYN-118

Nov. 24, 2011

Companies collaborate on DNA-based therapy for pulmonary arterial hypertension

Nov. 22, 2011

Ajinomoto and Interprotein to collaborate on protein-protein interaction inhibitors

Nov. 21, 2011

Shionogi and Shire enter collaboration for two therapeutic agents for ADHD

Nov. 21, 2011

Alnylam Pharmaceuticals licenses InterfeRx to Sylentis

Nov. 21, 2011

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...